Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 3 open-market purchases and 0 sales; 171 institutions reported holding it in 13F filings for Q3 2026, worth $167.0M in total; no superinvestor holds it.
Holders of 5% or more of CMPX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Compass Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Tang Capital Management LLC | 13G/A | 9.99%17.2M shares | 0.00 ppfrom 9.99% | Jan 16, 20255 filings | Nov 14, 2025 | SEC |
| OrbiMed Advisors LLC | 13D/A | 8.90%15.2M shares | −2.10 ppfrom 11.00% | Jul 14, 20216 filings | Aug 15, 2025 | SEC |
| Suvretta Capital Management, LLC | 13G/A | 8.20%14.1M shares | +3.00 ppfrom 5.20% | Aug 13, 20252 filings | Aug 21, 2025 | SEC |
| BlackRock, Inc. | 13G | 5.20%9.27M shares | +0.60 ppfrom 4.60% | Feb 4, 20253 filings | Jan 21, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
45 Schedule 13D and 13G filings on Compass Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 20266:55 AM ET | State Street Corp | 13G | 4.30%7.74M shares | −1.20 ppfrom 5.50%Below 5% | Sep 30, 2026 | SEC |
| Aug 14, 20263:59 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13G/A | 4.00%7.21M shares | −1.10 ppfrom 5.10%Below 5% | Jun 30, 2026 | SEC |
| Aug 7, 20269:13 AM ET | State Street Corp | 13G | 5.50%9.95M shares | New | Jun 30, 2026 | SEC |
| May 15, 20264:06 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 4.30%7.76M shares | −0.80 ppfrom 5.10%Below 5% | Mar 31, 2026 | SEC |
| Feb 13, 20264:30 PM ET | Blackstone Holdings II L.P.and 7 others | 13G/A | 3.40%6.13M shares | –Below 5% | Dec 31, 2025 | SEC |
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G | 5.20%9.27M shares | +0.60 ppfrom 4.60% | Dec 31, 2025 | SEC |
| Nov 14, 20256:35 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13G | 5.10%9.00M shares | New | Sep 30, 2025 | SEC |
| Nov 14, 20254:17 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 9.99%17.2M shares | 0.00 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Nov 14, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 9.99%17.2M shares | +0.19 ppfrom 9.80% | Sep 30, 2025 | SEC |
| Oct 29, 20255:24 PM ET | Biotechnology Value Fund L Pand 9 others | 13G | 5.10%8.75M shares | New | Oct 22, 2025 | SEC |
| Aug 21, 20259:07 AM ET | Suvretta Capital Management, LLCand 2 others | 13G/A | 8.20%14.1M shares | +3.00 ppfrom 5.20% | Aug 13, 2025 | SEC |
| Aug 18, 20256:35 PM ET | Commander Aggregator, LPand 3 others | 13D/A | 4.50%7.79M shares | –Below 5% | Aug 14, 2025 | SEC |
| Aug 15, 20255:28 PM ET | OrbiMed Advisors LLCand 1 other | 13D/A | 8.90%15.2M shares | −2.10 ppfrom 11.00% | Aug 13, 2025 | SEC |
| Aug 14, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 9.80%13.5M shares | +1.80 ppfrom 8.00% | Jun 30, 2025 | SEC |
| Aug 14, 202510:49 AM ET | RTW Investments, LPand 1 other | 13G/A | 0.00%0 shares | −9.90 ppfrom 9.90%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20258:05 AM ET | RTW Investments, LPand 1 other | 13G/A | 9.90%9.47M shares | – | Jun 30, 2025 | SEC |
| Aug 13, 20258:21 PM ET | Suvretta Capital Management, LLCand 2 others | 13G | 5.20%7.15M shares | New | Jun 30, 2025 | SEC |
| Aug 12, 20254:29 PM ET | MPM Oncology Impact Management LP | 13G/A | 4.10%5.62M shares | −2.10 ppfrom 6.20%Below 5% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 4.60%6.40M shares | −0.40 ppfrom 5.00%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 8.00%11.1M shares | +2.60 ppfrom 5.40% | Mar 31, 2025 | SEC |
| Apr 11, 20257:21 PM ET | OrbiMed Advisors LLCand 3 others | 13D/A | 11.00%15.2M shares | – | Apr 9, 2024 | SEC |
| Feb 14, 20254:11 PM ET | MPM Oncology Impact Management LP | 13G | 6.20%8.57M shares | New | Dec 31, 2024 | SEC |
| Feb 12, 20259:39 AM ET | Adage Capital Partners GP, L.L.C.and 3 others | 13G/A | 4.36%5.99M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 4, 20253:45 PM ET | BlackRock, Inc. | 13G | 5.00%6.89M shares | New | Dec 31, 2024 | SEC |
| Jan 16, 20255:17 PM ET | Tang Capital Management LLCand 5 others | 13G | 5.40%7.40M shares | New | Jan 8, 2025 | SEC |
| Nov 14, 2024 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Aug 2, 2024 | Blackstone Holdings II L.P. | 13GOld format | – | New | – | SEC |
| Mar 22, 2024 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 7, 2024 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Feb 1, 2024 | Janus Henderson Group PLC | 13GOld format | – | New | – | SEC |
| Nov 27, 2023 | Adage Capital Partners GP, L.L.C. | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Foresite Capital Fund V, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2022 | Commander Aggregator, LP | 13DOld format | – | New | – | SEC |
| Nov 10, 2022 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 15, 2022 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Dec 30, 2021 | Rock Springs Capital Management LP | 13GOld format | – | New | – | SEC |
| Dec 17, 2021 | Anderson Errik | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2021 | Foresite Capital Fund V, L.P. | 13GOld format | – | New | – | SEC |
| Nov 9, 2021 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Jul 14, 2021 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell Compass Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Apr 9, 20256:58 PM ET | OrbiMed Genesis Master Fund, L.P.Director · Shareholder | 3.57M | $5.68M | Apr 9, 2025 | Jefferies LLC | SEC |
| Apr 9, 20256:51 PM ET | The Biotech Growth Trust PLCDirector · Shareholder | 3.57M | $5.68M | Apr 9, 2025 | Jefferies LLC | SEC |